Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Alzheimer's Disease

  Free Subscription


13.05.2019

1 Alzheimer Dis Assoc Disord
2 Alzheimers Dement
2 Am J Alzheimers Dis Other Demen
1 BMC Neurol
1 Brain Res
1 Curr Alzheimer Res
2 J Biol Chem
2 Neurobiol Aging
1 Neurology
1 Neuroscience
2 PLoS One
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. GLOVER CM, CoCroft S, James BD, Barnes LL, et al
    Perceptions of Risk Factors for Alzheimer Disease Among Community-Dwelling, Nondemented Older African Americans.
    Alzheimer Dis Assoc Disord. 2019 May 1. doi: 10.1097/WAD.0000000000000314.
    PubMed     Text format     Abstract available


    Alzheimers Dement


  2. Erratum to "Kallikrein-8 inhibition attenuates Alzheimer's disease pathology in mice" [Alzheimer's & Dementia 2016;12:1273-87.].
    Alzheimers Dement. 2019 May 4. pii: S1552-5260(19)30117.
    PubMed     Text format    

  3. SCHEEPERS LEJM, Jacobsson LTH, Kern S, Johansson L, et al
    Urate and risk of Alzheimer's disease and vascular dementia: A population-based study.
    Alzheimers Dement. 2019 May 2. pii: S1552-5260(19)30046.
    PubMed     Text format     Abstract available


    Am J Alzheimers Dis Other Demen

  4. MA SL, Tang NLS, Wat KHY, Tang JHY, et al
    Effect of CYP2D6 and CYP3A4 Genotypes on the Efficacy of Cholinesterase Inhibitors in Southern Chinese Patients With Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2019 May 7:1533317519848237.
    PubMed     Text format     Abstract available

  5. NAVEED M, Mubeen S, Khan A, Ibrahim S, et al
    Plasma Biomarkers: Potent Screeners of Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2019 May 9:1533317519848239.
    PubMed     Text format     Abstract available


    BMC Neurol

  6. CONNELLY PJ, Adams F, Tayar ZI, Khan F, et al
    Peripheral vascular responses to acetylcholine as a predictive tool for response to cholinesterase inhibitors in Alzheimer's disease.
    BMC Neurol. 2019;19:88.
    PubMed     Text format     Abstract available


    Brain Res

  7. TIAN M, Lin X, Wu L, Lu J, et al
    Angiotensin II Triggers Autophagy and Apoptosis in PC12 Cell Line: An in vitro Alzheimer's Disease Model.
    Brain Res. 2019 May 2. pii: S0006-8993(19)30243.
    PubMed     Text format     Abstract available


    Curr Alzheimer Res

  8. MAZZON G, Ajcevic M, Cattaruzza T, Menichelli A, et al
    Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer's Disease and Correlation with Cerebral Hypoperfusion Pattern.
    Curr Alzheimer Res. 2019 May 6. pii: CAR-EPUB-98383.
    PubMed     Text format     Abstract available


    J Biol Chem

  9. LIU S, Ando F, Fujita Y, Liu J, et al
    A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
    J Biol Chem. 2019 May 9. pii: RA118.006420. doi: 10.1074/jbc.RA118.006420.
    PubMed     Text format     Abstract available

  10. HUR WS, Mazinani N, Lu XJD, Yefet LS, et al
    Coagulation factor XIIIa cross-links amyloid beta into dimers and oligomers and to blood proteins.
    J Biol Chem. 2019;294:390-396.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  11. TIMMERS M, Tesseur I, Bogert J, Zetterberg H, et al
    Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease.
    Neurobiol Aging. 2019;79:131-141.
    PubMed     Text format     Abstract available

  12. JACOBS KR, Lim CK, Blennow K, Zetterberg H, et al
    Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-beta and tau.
    Neurobiol Aging. 2019;80:11-20.
    PubMed     Text format     Abstract available


    Neurology

  13. VERMUNT L, van Paasen AJL, Teunissen CE, Scheltens P, et al
    Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal.
    Neurology. 2019 May 8. pii: WNL.0000000000007609.
    PubMed     Text format     Abstract available


    Neuroscience

  14. CHERNYUK D, Zernov N, Kabirova M, Bezprozvanny I, et al
    Antagonist of Neuronal Store-Operated Calcium Entry Exerts Beneficial Effects in Neurons Expressing PSEN1DeltaE9 Mutant Linked to Familial Alzheimer Disease.
    Neuroscience. 2019 May 2. pii: S0306-4522(19)30292.
    PubMed     Text format     Abstract available


    PLoS One

  15. BAILLY L, David R, Chevrier R, Grebet J, et al
    Alzheimer's disease: Estimating its prevalence rate in a French geographical unit using the National Alzheimer Data Bank and national health insurance information systems.
    PLoS One. 2019;14:e0216221.
    PubMed     Text format     Abstract available

  16. SIDDARTH P, Burggren AC, Merrill DA, Ercoli LM, et al
    Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.
    PLoS One. 2018;13:e0208358.
    PubMed     Text format     Abstract available


    Science

  17. LIU Y, Aguzzi A
    Immunotherapy for neurodegeneration?
    Science. 2019;364:130-131.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: